Speaker illustration

Mr Yvan Devaux

Luxembourg Institute of Health, Luxembourg (Luxembourg)

Member of:

European Society of Cardiology
Heart Failure Association

Dr Devaux's background training is in Biological Sciences, focusing on Biology and Health during his PhD in France and a post-doc in the US. He joined the Luxembourg Institute of Health (LIH) in 2005 and became Head of the Cardiovascular Research Unit in 2017. His main interest is the discovery and validation of novel RNA biomarkers and therapeutic targets of cardiac disease. He is especially interested in translational research, noncoding RNAs, myocardial infarction, heart failure and cardiac arrest. He founded the Cardiolinc network in 2014 and currently chairs the EU-CardioRNA COST Action CA17129, a H2020-funded network of researchers from 37 EU and international partner countries aiming to advance the research on RNAs in cardiovascular disease through collaboration and networking activities. He has contributed 120+ scientific articles and is involved in several national and international research projects focusing on cardiovascular biomarkers.

Role of non coding RNAs in cardiovascular diseases

Event: ESC Congress 2018

Topic: Cardiac Biology and Physiology

Session type: Moderated Posters

Thumbnail

New heart failure therapies at the horizon

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Genetics, Epigenetics, ncRNA

Session type: Symposium

Thumbnail

Genetics and gene therapy in cardiovascular diseases

Event: ESC CONGRESS 2017

Topic: Genetics and gene therapy

Session type: Advances in Science

Thumbnail

This platform is supported by

logo Novo Nordisk